Poniard Pharmaceuticals, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late annual filing notification for FY 2011

ended 09/30/11 Q3

ended 06/30/11 Q2

ended 03/31/11 Q1

ended 12/31/10 FY 2010

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Perry Michael S

Perry Michael S

Jackson Michael K

Jackson Michael K

Perry Michael S

News Filter

Change in Directors, Officers or Compensation, Other Events, Financial Statements or Exhibits

Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin Board

Poniard Pharmaceuticals and Allozyne Terminate Planned Merger

Announces Shareholders Approve Merger With ALLOZYNE

Reports Third Quarter 2011 Financial Results

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC